Vita

• from Rotenburg Wümme, Germany

• BSc in Biotechnology, Technical University Brunswick; MSc Molecular Biomedicine, Heinrich-Heine University Düsseldorf

• CiM-IMPRS member since 2022

Research project

Analysis of the anti-bacterial activity of the MEK inhibitor Zapnometinib (ATR-002) and the interaction with antibiotic treatment in coinfection with influenza A viruses and Streptococcus pneumoniae
Supervisor: Dr. Yvonne Börgeling, Prof. Dr. Stephan Ludwig